VAERS reports by lot

Moderna COVID-19 lot 088021A: VAERS reports

51 VAERS reports list lot 088021A as a Moderna COVID-19 vaccine, received between 2021-08-03 and 2023-08-17. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
51
Reports
14%
Marked serious
0
With a death outcome
10
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
General / Systemic (non-local)4820%
Neurological4318%
Injection-site / Local reaction3012%
Gastrointestinal2310%
Cardiac / Cardiovascular219%
Musculoskeletal219%
Dermatological (non-injection-site)177%
Allergic / Anaphylactic135%
Respiratory135%
Reproductive / Menstrual62%
Psychiatric / Neuropsychiatric42%
Autoimmune / Immune-mediated21%

Where reports came from

U.S. state of the reporter, where given (top 12).

Texas7
North Carolina5
New York4
Minnesota3
Virginia3
Louisiana3
California3
New Mexico2
New Jersey2
Washington2
Alabama2
Indiana2

Reports by month received

2021-0822
2021-098
2021-105
2021-113
2021-123
2022-012
2022-024
2022-042
2022-071
2023-081

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.